Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Phone Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Phone Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / UK approves Pfizer-BioNTech's COVID-19 vaccine; first doses expected next week
  • World

    UK approves Pfizer-BioNTech's COVID-19 vaccine; first doses expected next week

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Dec 02, 2020, 02:18 pm
    UK approves Pfizer-BioNTech's COVID-19 vaccine; first doses expected next week
  • The United Kingdom on Wednesday gave emergency approval to Pfizer and BioNTech's COVID-19 vaccine, becoming the first Western country to allow mass immunization against the viral disease.

    The vaccine, which has been shown to have 95% efficacy in late-stage clinical trials, will be made available across the country for at-risk groups starting next week.

    The UK has pre-ordered 40 million doses of the vaccine.

  • In this article
    Vaccine meets 'strict standards of safety, quality, effectiveness' 'Panel to publish advice for priority groups to receive vaccine' 10 million doses to arrive this year: Health Secretary US, Europe to approve vaccine within weeks Vaccine uses mRNA technology; 95% effective Vaccine will help reduce hospitalizations among high-risk groups: BioNTech co-founder 'Historic moment in fight against COVID-19'
  • Details

    Vaccine meets 'strict standards of safety, quality, effectiveness'

    Vaccine meets 'strict standards of safety, quality, effectiveness'
  • The vaccine has been given emergency approval by the Medicines and Healthcare Products Regulatory Authority (MHRA).

    Experts at MHRA concluded that the vaccine has met "strict standards of safety, quality, and effectiveness," a Department of Health and Social Care spokesperson was quoted as saying by The Guardian.

    Russia and China have already approved vaccines, albeit without the results of large-scale efficacy tests.

  • Quote

    'Panel to publish advice for priority groups to receive vaccine'

  • The spokesperson added, "The joint committee on vaccination and immunization will shortly also publish its latest advice for the priority groups to receive the vaccine, including care home residents, health and care staff, the elderly and the clinically extremely vulnerable."

  • Availability

    10 million doses to arrive this year: Health Secretary

  • The delivery of the 40 million doses will start immediately. Health Secretary Matt Hancock said he expects 10 million doses to arrive this year.

    Care home residents are first in line to receive the vaccine, followed by people aged over 80 and the National Health Service staff.

    Pfizer and BioNTech said they can supply 50 million doses in 2020 and 1.3 billion by 2021-end.

  • Other countries

    US, Europe to approve vaccine within weeks

    US, Europe to approve vaccine within weeks
  • The United States, which has pre-ordered 100 million doses, and Europe, which has bought 200 million, are also expected to approve the vaccine within weeks. The UK's approval of the vaccine before the US—particularly one developed by an American company—is set to put pressure on US regulators.

    Notably, the MHRA has approved the vaccine within just a week, which is unprecedented.

  • Vaccine

    Vaccine uses mRNA technology; 95% effective

  • Another first attached to the Pfizer-BioNTech's vaccine is that the messenger RNA (mRNA) technology it uses has never been used for an approved vaccine.

    Late-stage trial data found the vaccine has 95% efficacy and was equally effective among younger and older volunteers.

    The vaccine has to be kept at low temperatures of -70°C, which is a challenge for its delivery.

  • Quote

    Vaccine will help reduce hospitalizations among high-risk groups: BioNTech co-founder

    Vaccine will help reduce hospitalizations among high-risk groups: BioNTech co-founder
  • Ugur Sahin, the CEO and co-founder of BioNTech, said in a statement, "The emergency use authorization in the UK will mark the first time citizens outside of the trials will have the opportunity to be immunized against COVID-19."

    He added, "We believe that the rollout of the vaccination program in the UK will reduce the number of people in the high-risk population being hospitalized."

  • Quote

    'Historic moment in fight against COVID-19'

  • "Today's emergency use authorization in the UK marks a historic moment in the fight against COVID-19," Pfizer CEO Albert Bourla said, "We are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world."

  • Pfizer
  • Europe
  • United Kingdom
  • National Health Service
  • United States of America
  •  
Latest News
  • Centre increases vaccine doses to Maharashtra; 'not enough,' says state
    Centre increases vaccine doses to Maharashtra; 'not enough,' says state
    Politics
  • Indian social media platform ShareChat raises $502 million, becomes unicorn
    Indian social media platform ShareChat raises $502 million, becomes unicorn
    Business
  • After Aamir Khan, Amit Sadh, Samir Soni quit social media
    After Aamir Khan, Amit Sadh, Samir Soni quit social media
    Entertainment
  • Nagma tests positive for COVID-19 after receiving first vaccine shot
    Nagma tests positive for COVID-19 after receiving first vaccine shot
    Entertainment
  • SC dismisses Maharashtra government, Anil Deshmukh's plea against CBI probe
    SC dismisses Maharashtra government, Anil Deshmukh's plea against CBI probe
    India
Related Timelines
  • After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
    After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
    World
  • Can prepare vaccine against mutated virus in 6 weeks: BioNTech
    Can prepare vaccine against mutated virus in 6 weeks: BioNTech
    Science
  • US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
    US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
    World
  • Moderna vaccine has 'no specific safety concerns,' says US regulator
    Moderna vaccine has 'no specific safety concerns,' says US regulator
    Science
Trending Topics
Prince Harry Meghan Markle Coronavirus
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News Real Madrid ISRO Yoga
Honda Batman Football News BMW Mark Zuckerberg Vaccine Reliance Jio OPPO Food News, Healthy Recipes Apple
Royal Challengers Bangalore Toyota Fashion Tips Sensex Mercedes Manchester City Katrina Kaif Prince Harry Meghan Markle Sidharth Malhotra
Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021